Sponsored Links

Nycomed Recently Announced That Roflumilast, Improved Lung Function And Reduced Exacerbations In Patients With Moderate To Severe COPD PDF Print E-mail
Medical News - COPD
COPD is an under-diagnosed progressive lung disease that may lead to death. In Canada, approximately 500,000 people over the age of 35 have been diagnosed with COPD, and it is estimated that an almost equal number of middle-aged Canadians may also have COPD, but are not aware of it.i In fact, by 2020, it is estimated that COPD will be the third leading cause of death worldwide.ii Roflumilast, a once-a-day oral tablet, would be the first in a new class of treatment for COPD.

Read more: COPD News From Medical News Today